Chen Bihua, Director at BridgeBio Oncology Therapeutics, Inc., Granted Stock Options

Bihua Chen, a director and ten percent owner of BridgeBio Oncology Therapeutics, Inc. (BBOT), was granted 31,675 stock options on June 16, 2026. The options have an exercise price of $7.73 and expire on June 15, 2036. These options vest in full on the earlier of the first anniversary of the grant date or the next Annual Meeting of Stockholders, provided service to the company continues. This transaction is reported on Form 4.